In vivo protective effects of urocortin on ischemia-reperfusion injury in rat heart via free radical mechanisms.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Canadian Journal of Physiology and Pharmacology

• Publication date

  2005-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1139/Y05-033PMID 16049545
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Urocortin II Inhibits the Apoptosis of Mesenteric Arterial Smooth Muscle Cells Via L-type Calcium Channels in Spontaneously Hypertensive Rats

  2006cited by this paper
• CRF and CRF receptors: role in stress responsivity and other behaviors.

  2004cited by this paper
• Gö 6983 Exerts Cardioprotective Effects in Myocardial Ischemia/Reperfusion

  2004cited by this paper
• Effect of urocortin on L-type calcium currents in adult rat ventricular myocytes.

  2004cited by this paper
• Hypothermic Protection in Rat Focal Ischemia Models: Strain Differences and Relevance to “Reperfusion Injury”

  2004cited by this paper
• In Vivo Evaluation of Retinal Injury After Transient Ischemia in Hypertensive Rats

  2004cited by this paper
• Vitamins, Supplements, Herbal Medicines, and Arrhythmias

  2004cited by this paper
• Calpain Inhibitor I Reduces Intestinal Ischemia-Reperfusion Injury in the Rat

  2004cited by this paper
• The cardiovascular physiologic actions of urocortin II: acute effects in murine heart failure.

  2004cited by this paper
• Cardioprotective Effect of Zofenopril in Perfused Rat Heart Subjected to Ischemia and Reperfusion

  2004cited by this paper
• Imbalance Between Tissue Inhibitor of Metalloproteinase-4 and Matrix Metalloproteinases During Acute Myoctardial Ischemia-Reperfusion Injury

  2003cited by this paper
• HFE Mutation and Dietary Iron Content Interact to Increase Ischemia/Reperfusion Injury of the Heart in Mice

  2003cited by this paper
• TGF-beta 1 attenuates myocardial ischemia-reperfusion injury via inhibition of upregulation of MMP-1.

  2003cited by this paper
• Activation of Peroxisome Proliferator–Activated Receptor-&agr; Protects the Heart From Ischemia/Reperfusion Injury

  2003cited by this paper
• Vasodilative Effects of Urocortin II via Protein Kinase A and a Mitogen-activated Protein Kinase in Rat Thoracic Aorta

  2003cited by this paper
• Hearts From Rodents Exposed to Intermittent Hypoxia or Erythropoietin Are Protected Against Ischemia‐Reperfusion Injury

  2003cited by this paper
• KATP Channel Gene Expression Is Induced by Urocortin and Mediates Its Cardioprotective Effect

  2002cited by this paper
• Intracellular Action of Matrix Metalloproteinase-2 Accounts for Acute Myocardial Ischemia and Reperfusion Injury

  2002cited by this paper
• Close Association Between the Reduction in Myocardial Energy Metabolism and Infarct Size: Dose-Response Assessment of Cyclosporine

  2002cited by this paper
• The corticotropin-releasing factor/urocortin system and alcohol.

  2002cited by this paper
• Relative importance of enhanced glucose uptake versus attenuation of long-chain acyl carnitines in protecting ischemic myocardium

  2002cited by this paper
• Cardiovascular actions of CRH and urocortin: an update.

  2001cited by this paper
• Relation of Cyclic Nucleotide Ratios to Ischemic and Reperfusion Injury in Nitric Oxide–Donor Treated Rat Hearts

  2001cited by this paper
• Peripheral corticotropin-releasing hormone and urocortin in the control of the immune response.

  2001cited by this paper
• Antioxidant vitamins and enzymatic and synthetic oxygen-derived free radical scavengers in the prevention and treatment of cardiovascular disease.

  2001influential reference
• The neurobiology of urocortin.

  2000cited by this paper
• Urocortin Protects against Ischemic and Reperfusion Injury via a MAPK-dependent Pathway*

  2000cited by this paper
• Ischemic preconditioning depends on interaction between mitochondrial KATP channels and actin cytoskeleton.

  1999cited by this paper
• Is the chemical gate of connexins voltage sensitive? Behavior of Cx32 wild-type and mutant channels.

  1999cited by this paper
• Ischemic preconditioning depends on interaction between mitochondrial KATP channels and actin cytoskeleton.

  1999cited by this paper
• The role of corticotropin-releasing factor and urocortin in the modulation of ingestive behavior.

  1999cited by this paper
• Experimental study on the scavenging effects of ginsenosides on oxygen free radicals using model of heterotopic heart transplantation in rats.

  1998cited by this paper
• The behavioural effects of corticotropin-releasing factor-related peptides in rats

  1998cited by this paper
• Potent suppressive effects of urocortin on splenic lymphocyte activity in rats

  1998cited by this paper
• Are calcium antagonists proarrhythmic?

  1997cited by this paper

• Urocortin I Protects against Myocardial Ischemia/Reperfusion Injury by Sustaining Respiratory Function and Cardiolipin Content via Mitochondrial ATP-Sensitive Potassium Channel Opening

  2022cites this paper
• Cardioprotective and Vasoprotective Effects of Corticotropin-Releasing Hormone and Urocortins: Receptors and Signaling

  2021cites this paper
• Cardiovascular Effects of Urocortin-2: Pathophysiological Mechanisms and Therapeutic Potential

  2019cites this paper
• Natural and synthetic peptides in the cardiovascular diseases: An update on diagnostic and therapeutic potentials.

  2019cites this paper
• Biological Effects of Licochalcones.

  2019cites this paper
• Urocortins: Actions in health and heart failure.

  2017cites this paper
• Characterization of urocortin as an anti-apoptotic protein in experimental ischemia-reperfusion model of the rat testis.

  2016cites this paper
• Cardiovascular effects of urocortin 2 and urocortin 3 in patients with chronic heart failure

  2016cites this paper
• Cardiovascular effects of the sirtuin and urocortin systems in humans

  2016cites this paper
• Evaluation antianginös wirkender Kanal- und Rezeptorblocker in einem koronaren Arteriogenesemodell der Ratte

  2016cites this paper
• Urocortin attenuates myocardial fibrosis in diabetic rats via the Akt/GSK-3β signaling pathway

  2016cites this paper
• The effects of vasoactive peptide urocortin 2 on hemodynamics in spontaneous hypertensive rat and the role of L-type calcium channel and CRFR2

  2015cites this paper
• Urocortin ameliorates diabetic cardiomyopathy in rats via the Akt/GSK-3β signaling pathway

  2015cites this paper
• Therapeutic effects of human urocortin-1, -2 and -3 in intracerebral hemorrhage of rats.

  2015cites this paper
• Chronic Urocortin 2 Administration Improves Cardiac Function and Ameliorates Cardiac Remodeling After Experimental Myocardial Infarction

  2015cites this paper
• The effects of neuropeptide urocortin 2 on the spontaneous discharge and glutamatergic neurotransmission of striatum neurons.

  2015cites this paper
• Role of licochalcone C in cardioprotection against ischemia/reperfusion injury of isolated rat heart via antioxidant, anti-inflammatory, and anti-apoptotic activities.

  2015cites this paper
• Urocortin 2 in cardiovascular health and disease.

  2015cites this paper
• The role of urocortin-2 in pulmonary arterial hypertension

  2014cites this paper
• The role of urocortins in the cardiovascular system.

  2014cites this paper
• Novel Management of Heart Failure

  2013cites this paper
• Systemic administration of urocortin after intracerebral hemorrhage reduces neurological deficits and neuroinflammation in rats

  2012cites this paper
• Clinical Perspectives of Urocortin and Related Agents for the Treatment of Cardiovascular Disease

  2012cites this paper
• Therapeutic benefit of urocortin in rats with intracerebral hemorrhage.

  2012cites this paper
• Urocortin 2 sustains haemodynamic and renal function during introduction of beta-blockade in experimental heart failure

  2011cites this paper
• New targets of urocortin-mediated cardioprotection

  2010cites this paper
• Corticotropin-releasing factor signaling and visceral response to stress

  2010cites this paper
• Novel Neuroprotective Strategies in Ischemic Retinal Lesions

  2010cites this paper
• Acute effects of urocortin 2 on cardiac function and propensity for arrhythmias in an animal model of hypertension‐induced left ventricular hypertrophy and heart failure

  2010cites this paper
• Corticotropin‐releasing factor‐2 activation prevents gentamicin‐induced oxidative stress in cells derived from the inner ear

  2010cites this paper
• Effect of long-term treatment with urocortin on the activity of somatic angiotensin-converting enzyme in spontaneously hypertensive rats.

  2010cites this paper
• Urocortin 2 protects against retinal degeneration following bilateral common carotid artery occlusion in the rat.

  2009cites this paper
• Urocortin 2 Inhibits Furosemide-Induced Activation of Renin and Enhances Renal Function and Diuretic Responsiveness in Experimental Heart Failure

  2009cites this paper
• Urocortin inhibits mesenteric arterial remodeling in spontaneously hypertensive rats.

  2009cites this paper
• Investigating the role of the JAK/STAT and MAPK pathways in ischaemia/reperfusion injury and inflammation

  2009cites this paper
• Urocortin: a beneficial or detrimental agent to endothelium?

  2008cites this paper
• Urocortin 2 combined with angiotensin-converting enzyme inhibition in experimental heart failure.

  2008cites this paper
• Urocortins in heart failure and ischemic heart disease.

  2008cites this paper
• Urocortin ameliorates diabetic nephropathy in obese db/db mice

  2008cites this paper
• Corticotropin-releasing factor family and its receptors: tumor therapeutic targets?

  2007cites this paper
• Urocortin 1 administration from onset of rapid left ventricular pacing represses progression to overt heart failure.

  2007cites this paper
• Hydroxyl radical induced structural changes of collagen

  2007cites this paper
• UROCORTIN 1 ADMINISTRATION FROM ONSET OF RAPID LEFT VENRICULAR PACING REPRESSES PROGRESSION TO OVERT HEART FAILURE

  2007cites this paper
• Effects of intravenous urocortin on angiotensin-converting enzyme in rats.

  2006cites this paper
• Urocortin II Inhibits the Apoptosis of Mesenteric Arterial Smooth Muscle Cells Via L-type Calcium Channels in Spontaneously Hypertensive Rats

  2006cites this paper
• Effects of urocortin via ion mechanisms or CRF receptors?

  2005cites this paper
• Urocortin reduces the viability of adult rat vascular smooth muscle cells via inhibiting L-type calcium channels.

  2005cites this paper